Q2 2026 saw revenue of $199.8M, down 7% year-over-year but up 2% sequentially, with EBITDA margin at 16.8%. Demand is stabilizing, especially in medical and photonics, while automotive remains soft. Guidance for Q3 is $195M-$205M revenue and 17%-20% EBITDA margin.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.